Beta Bionics BBNX
NASDAQ BBNX
$16.52 -0.43 (-2.54%)
At close: Nov 10, 2026 · 4:00 PM EST

Beta Bionics (BBNX) Return on Equity [ROE] (2025 - 2026)

Updated

Beta Bionics' Return on Equity [ROE] came in at -25.27% for Q3 2026, down 5.36 percentage points from -19.91% a year earlier but up 2.39 percentage points from the prior quarter.

Analysis

Beta Bionics (BBNX) Return on Equity [ROE] (2025 - 2026) Analysis & Trends

For FY2025, Beta Bionics' Return on Equity [ROE] was -287.57%.

  • The five-year range for quarterly Return on Equity [ROE] is -143.98% (Q1 2025) to -17.98% (Q2 2025).
  • Business Quant data shows BBNX's Return on Equity [ROE] at -27.66% (Q2 2026), -23.78% (Q1 2026) and -20.86% (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 13.20%
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 9.09%
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 8.15%
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn 17.28%
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 17.46%
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn -4.01%
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 13.69%
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn 9.36%
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 4.56%
10 Beta Bionics 898.08 Mn 58.74 Mn 20.33 Mn -25.65%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -25.65%
Jun 30, 2026 -27.87%
Mar 31, 2026 -23.90%
Dec 31, 2025 -25.02%
Sep 30, 2025 -26.01%
Jun 30, 2025 -23.79%
Mar 31, 2025 -206.83%
API Access

Beta Bionics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BBNX&period=max&api_key=YOUR_API_KEY